SCHEMBL29073232

SCHEMBL29073232

O=C(/C(=C/c1ccc(Cl)cc1)CCl)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.55
CES1 P23141 3/20 0.55
MAOB P27338 1/20 0.49
NPSR1 Q6W5P4 3/20 0.47
ALDH1A1 P00352 3/20 0.47
HTT P42858 3/20 0.47
NPC1 O15118 2/20 0.47
LMNA P02545 2/20 0.47
MAPT P10636 2/20 0.47
RAB9A P51151 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
CYP2C9 P11712 2/20 0.47
MEN1 O00255 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C19 P33261 1/20 0.47
KMT2A Q03164 1/20 0.47
GLA P06280 1/20 0.47
GRIK1 P39086 1/20 0.47
BRAF P15056 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20415230 0.86 CES2 (0.53) CES2CES1MAOBNPSR1ALDH1A1
SCHEMBL20415256 0.82 EGFR (0.49) CES2CES1MAOBNPSR1ALDH1A1
SCHEMBL26665153 0.80 CES2 (0.57) CES2CES1MAOBNPSR1ALDH1A1
SCHEMBL29293530 0.79 ALDH1A1 (0.46) CES2CES1MAOBNPSR1ALDH1A1
SCHEMBL20415259 0.79 OPRK1 (0.46) CES2CES1MAOBNPSR1ALDH1A1
SCHEMBL9859751 0.78 HTT (0.60) CES2CES1MAOBNPSR1ALDH1A1
SCHEMBL11099529 0.78 CA12 (0.48) CES2CES1MAOBNPSR1ALDH1A1
SCHEMBL13484610 0.78 CES2 (0.44) CES2CES1MAOBNPSR1ALDH1A1
SCHEMBL20415346 0.78 NTSR1 (0.45) CES2CES1MAOBNPSR1ALDH1A1
SCHEMBL20415255 0.77 CES2 (0.58) CES2CES1MAOBNPSR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4397652-A2 3-(PHENYL)-2-(AMINOMETHYL)-1-PHENYL-2-PROPEN-1-ONE DERIVATIVES AS INHIBITORS OF THE N-TERMINAL DOMAIN OF THE ANDROGEN RECEPTOR FOR TREATING PROSTATE CANCER The Regents of the University of California (US) 2024-07-10 EP disclosed
CN-110325508-B Inhibitors of the N-terminal domain of androgen receptor 加利福尼亚大学董事会 2023-06-30 CN disclosed